FIELD: biotechnology.
SUBSTANCE: group of inventions is described, including an adeno-associated virus (AAV) for retinal cell transduction, a pharmaceutical composition for gene transfer into retinal cells, the use of AAV for the treatment of damage to photoreceptor cells, the in vitro use of AAV for retinal cell nucleus transduction, and a kit for gene transfer into retinal cells.
EFFECT: invention expands the arsenal of agents for retinal cell transduction.
14 cl, 16 dwg, 2 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
VIRIONS OF AN ADENO-ASSOCIATED VIRUS WITH A VARIANT CAPSID AND METHODS FOR USING THEM | 2017 |
|
RU2742724C1 |
VIRIONS OF ADENO-ASSOCIATED VIRUS WITH OPTIONAL CAPSID AND METHODS OF THEIR USE | 2012 |
|
RU2611202C2 |
RECOMBINANT VIRAL VECTORS WITH MODIFIED TROPISM AND WAYS OF THEIR USE FOR TARGETED INTRODUCTION OF GENETIC MATERIAL INTO HUMAN CELLS | 2018 |
|
RU2809246C2 |
METHODS FOR AAV DETECTION | 2017 |
|
RU2771622C2 |
METHODS AND COMPOSITIONS FOR THE TREATMENT OF DISORDERS AND DISEASES RELATED TO RDH12 | 2017 |
|
RU2764920C2 |
ENHANCEMENT OF TISSUE-SPECIFIC GENE DELIVERY BY CAPSID MODIFICATION | 2019 |
|
RU2801217C2 |
ADENO-ASSOCIATED VIRUS VECTOR | 2015 |
|
RU2743382C2 |
ADENO-ASSOCIATED VIRAL VECTORS FOR TREATMENT OF MYOCILIN (MYOC) GLAUCOMA | 2015 |
|
RU2746991C2 |
VECTOR, METHOD FOR TREATING CHOROIDITIS, METHOD FOR SELECTIVE EXPRESSION OF POLYNUCLEOTIDE | 2014 |
|
RU2723101C2 |
COMPOSITION AND METHODS FOR HIGHLY EFFICIENT GENE TRANSFER USING AAV CAPSID VARIANTS | 2013 |
|
RU2683497C2 |
Authors
Dates
2023-03-29—Published
2018-10-16—Filed